CD274 and neoplasm: Of relevance are recent results on TGF-β-targeted therapy showing synergism with anti-PDL1- based treatment by dampening the tumor immunosuppressive microenvironment and favoring T cell trafficking to the tumor (Mariathasan et al., 2018).